Fadrozole
CGS-16949A; Fadrozole Hydrochloride; Fadrozole Monohydrochloride; CGS 16949A; CGS16949A; Hydrochloride, Fadrozole; Monohydrochloride, Fadrozole
A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.